MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.
MedGenome is a developer of sequencing genomics-based diagnostics and research platform intended to improve global health. The company's platform applies genomics technologies, bioinformatics, computing, and big data analytics to the genetically diverse and large population to understand the genetic basis of cancer, metabolic disorders, eye disorders, and other rare diseases, enabling the healthcare industry to develop deep insights into diseases at the genetic and molecular level.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 30, 2022 | Series Unknown | $50M | 3 | Novo Holdings | — | Detail |
Jul 15, 2021 | Series Unknown | ₹1.23B | 1 | International Finance Corporation | — | Detail |
Apr 1, 2020 | Series D | $55M | 3 | LeapFrog Investments | — | Detail |
Jan 1, 2019 | Series Unknown | — | 1 | InnoVen Capital | — | Detail |
Mar 5, 2018 | Series C | $10M | 3 | HDFC ERGO General Insurance Company Limited | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Novo Holdings | Yes | Series Unknown |
International Finance Corporation | Yes | Series Unknown |
InnoVen Capital | Yes | Series Unknown |
HDFC ERGO General Insurance Company Limited | Yes | Series C |
Sequoia Capital India | Yes | Series C |
Papillon Capital | Yes | Series A |
LeapFrog Investments | — | Series Unknown |
Sofina | — | Series Unknown |
Sequoia Capital | — | Series D |
HDFC Mutual Fund | — | Series C |